Friday, November 6, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analysts Price Targets for Universal Health Services NYSE UHS

Elaine Mendonca by Elaine Mendonca
February 29, 2024
in Breaking News
0
0
SHARES
51
VIEWS
Share on FacebookShare on Twitter

Analyst Sarah James from Cantor Fitzgerald maintains her Underweight rating on Universal Health Services (NYSE: UHS) but has increased the price target to $156 from $148. As of February 29, 2024, the average price target for UHS stands at $173.83, with a high forecast of $190.00 and a low forecast of $161.00, suggesting a 5.79% change.

Other analysts have provided their own price targets, including Credit Suisse at $163.00, Barclays at $142.00, and Deutsche Bank at $155 (up from $145). The varying opinions from analysts indicate a range of perspectives on Universal Health Services’ stock performance and price targets.

Universal Health Services, Inc. (UHS) Stock Soars on February 29, 2024: Positive Performance and Strong Opening

On February 29, 2024, Universal Health Services, Inc. (UHS) saw a positive performance in the stock market. According to data from CNN Money, UHS was trading near the top of its 52-week range and above its 200-day simple moving average. This indicates that the stock has been performing well over the past year and is currently in an upward trend.

The price of UHS shares increased by $3.68 since the market last closed, representing a 2.28% rise. The stock opened at $163.13, which was $1.40 higher than its previous close. This strong opening suggests that investors were optimistic about the company’s prospects on that day.

Universal Health Services, Inc. (UHS) Reports Strong Financial Performance for 2023: Revenue and EPS Growth Signals Stability and Potential

On February 29, 2024, Universal Health Services, Inc. (UHS) reported its financial performance for the past year and the fourth quarter. According to data from CNN Money, UHS generated a total revenue of $14.28 billion over the past year, which represents a 6.59% increase compared to the previous year. In the fourth quarter alone, the company brought in $3.70 billion in revenue, showing a 3.95% increase from the previous quarter.

In terms of net income, UHS reported a total of $717.79 million for the year, up 6.36% from the previous year. However, in the fourth quarter, the net income remained flat at $216.38 million. Despite the quarterly stagnation, the annual increase in net income is a positive sign for the company’s financial health.

Earnings per share (EPS) also saw significant growth for UHS. The company reported an EPS of $10.23 for the year, marking an 11.92% increase from the previous year. In the fourth quarter, the EPS rose to $3.16, showing a substantial 31.79% increase from the previous quarter.

Overall, UHS’s stock performance on February 29, 2024, reflects a strong financial performance over the past year, with steady revenue growth and increasing earnings per share. Investors may view these positive indicators as a sign of the company’s stability and potential for future growth.

Tags: UHS
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Renewable energy

Imperial Oil AMEX IMO Stock Analysis Impressive Performance and Growth Potential

Food Retailers Stock Bull Market

Etsy Unusual Options Activity Analysis Potential Market Shift on the Horizon

Analyst Sentiments Towards Mirum Pharmaceuticals A Mixed Bag

Recommended

indiemiconductor Stock

Indie Semiconductor Shares Face Technical Headwinds

1 year ago
BioNTech Stock

BioNTech Secures CureVac Acquisition in Landmark mRNA Deal

11 months ago
Food Retailers Market Capitalization

Victorias Secret Reports Strong Earnings Growth and Strategic Initiatives for Future Success

3 years ago

CNH Industrials Financial Report for Q4 2023 Meeting Expectations and Predicting a Slowdown in 2024

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum DroneShield Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Profits Show Up Beyond AI, Even When Deal Premiums Don’t

Pharma Pays for the Rotation While Crypto Hunts for a Floor

Tech Loses $1 Trillion, but the Rest of the Market Holds

Alphabet’s Cloud Doubles, Its Cash Turns Negative, the Stock Sinks

Margins Over Stories: Who Delivers Before the Fed and Big Tech

UPS and Coca-Cola Raise Guidance by Charging More, Not Selling More

Trending

Fastly Stock
Newsletter

Maersk Lifts Guidance a Third Time, and the Stock Still Sinks

by Stephanie Dugan
November 5, 2026
0

Dear readers, Raised guidance was supposed to be the safe harbor of earnings season. Maersk has tested...

AMD Stock

Democrats Win, and the Market Sorts Solar From Musk and Defense

November 4, 2026
Apple Stock

Good Quarters, Heavy Selling: Cash Flow Beats Growth on Election Day

November 3, 2026
Lumentum Stock

Profits Show Up Beyond AI, Even When Deal Premiums Don’t

November 2, 2026
Bitcoin Stock

Pharma Pays for the Rotation While Crypto Hunts for a Floor

October 31, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Maersk Lifts Guidance a Third Time, and the Stock Still Sinks
  • Democrats Win, and the Market Sorts Solar From Musk and Defense
  • Good Quarters, Heavy Selling: Cash Flow Beats Growth on Election Day

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com